| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
84,190,000 |
| Market
Cap: |
10.38(B) |
| Last
Volume: |
427,350 |
Avg
Vol: |
426,189 |
| 52
Week Range: |
$67.31 - $141.53 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 983 |
| Guru Rank Value : 0 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Co. is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy, Limb-girdle muscular dystrophies and other neuromuscular and central nervous system related disorders. Co.'s commercial product, EXONDYS 51® (eteplirsen) Injection is indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
143,757 |
247,027 |
| Total Buy Value |
$0 |
$0 |
$13,295,068 |
$24,257,422 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
5 |
7 |
| Total Shares Sold |
4,396 |
27,731 |
42,731 |
43,589 |
| Total Sell Value |
$602,450 |
$3,499,041 |
$5,099,841 |
$5,194,152 |
| Total People Sold |
2 |
7 |
7 |
7 |
| Total Sell Transactions |
2 |
7 |
8 |
9 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Haywood George Weaver |
10% Owner |
– – • |
2008-03-24 |
4 |
B |
$1.51 |
$604 |
I/I |
400 |
1,070,530 |
1.42 |
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2008-03-24 |
4 |
B |
$1.49 |
$149,000 |
D/D |
100,000 |
7,305,875 |
2.45 |
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2008-03-12 |
4 |
B |
$1.44 |
$158,587 |
I/I |
110,130 |
1,070,130 |
1.5 |
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2008-03-11 |
4 |
B |
$1.39 |
$76,971 |
D/D |
55,375 |
7,205,875 |
2.45 |
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2008-03-10 |
4 |
B |
$1.28 |
$47,744 |
D/D |
37,300 |
7,150,500 |
2.37 |
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2008-02-20 |
4 |
B |
$1.41 |
$15,510 |
D/D |
11,000 |
7,113,200 |
2.37 |
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2008-02-19 |
4 |
B |
$1.41 |
$141,000 |
D/D |
100,000 |
7,102,200 |
2.45 |
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2008-02-15 |
4 |
B |
$1.34 |
$9,648 |
D/D |
7,200 |
7,002,200 |
2.37 |
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2008-02-13 |
4 |
B |
$1.42 |
$212,730 |
D/D |
150,000 |
6,995,000 |
2.45 |
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2008-02-12 |
4 |
B |
$1.38 |
$330,312 |
D/D |
240,000 |
6,845,000 |
2.45 |
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2008-02-11 |
4 |
B |
$1.21 |
$78,403 |
D/D |
65,000 |
6,605,000 |
2.45 |
- |
|
| Hudson Leslie |
CEO |
– – – |
2008-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
333,000 |
333,000 |
|
- |
|
| Hudson Leslie |
Chief Executive Officer |
• • – |
2008-02-08 |
4 |
A |
$0.00 |
$0 |
D/D |
333,000 |
333,000 |
|
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2007-12-31 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
960,000 |
|
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2007-12-31 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,540,000 |
|
- |
|
| Iversen Patrick L |
Sr VP of Research & Devlopment |
• – – |
2007-11-15 |
5 |
A |
$2.26 |
$6,500 |
D/D |
2,875 |
54,758 |
|
- |
|
| Price Ben Gil |
Director |
– • – |
2007-10-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
| Goolsbee William Alden |
Director |
– • – |
2007-10-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
5,000 |
|
- |
|
| Iversen Patrick L |
Sr VP of Research & Devlopment |
• – – |
2007-05-15 |
5 |
A |
$2.28 |
$6,417 |
D/D |
2,817 |
51,883 |
|
- |
|
| Iversen Patrick L |
Sr VP of Research & Devlopment |
• – – |
2006-11-15 |
5 |
A |
$3.29 |
$6,250 |
D/D |
1,900 |
49,066 |
|
- |
|
| Timmins Alan P |
President & COO |
• • – |
2006-11-15 |
5 |
A |
$3.29 |
$4,415 |
D/D |
1,342 |
69,882 |
|
- |
|
| Burger Denis R |
CEO |
• • – |
2006-11-15 |
5 |
A |
$3.29 |
$1,467 |
D/D |
446 |
171,024 |
|
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2006-08-10 |
4 |
S |
$2.68 |
$48,160 |
D/D |
(17,970) |
4,960,000 |
|
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2006-08-09 |
4 |
S |
$2.71 |
$222,301 |
D/D |
(82,030) |
4,977,970 |
|
- |
|
| Haywood George Weaver |
10% Owner |
– – • |
2006-07-27 |
4 |
S |
$2.60 |
$977,937 |
D/D |
(360,300) |
5,060,000 |
|
- |
|
524 Records found
|
|
Page 20 of 21 |
|
|
5.88 (5.01%) 
